Bionime Corporation (TPE:4737)
58.00
-1.10 (-1.86%)
Nov 20, 2026, 1:30 PM CST
Bionime Revenue
Bionime had revenue of 475.71M TWD in the quarter ending September 30, 2026, with 3.75% growth. This brings the company's total for the last twelve months to 1.73B, down -9.37% year-over-year. In the year 2025, Bionime had annual revenue of 1.84B, down -4.92%. That makes Bionime the 27,671st largest company in the world by revenue and 1,308th in Taiwan.
Revenue (ttm)
1.73B
Revenue Growth
-9.37%
P/S Ratio
2.59
Revenue / Employee
3.47M
Employees
500
Market Cap
4.49B
Revenue by Geography
- Other Countries 821.79M 44.7%
- Algeria 530.60M 28.9%
- China 184.76M 10.0%
- United States 134.55M 7.3%
- Republic of Belarus 88.69M 4.8%
- Switzerland 38.11M 2.1%
- United Arab Emirates 24.55M 1.3%
- Egypt 15.55M 0.8%
Fiscal year ended Dec 31, 2025 See the full Bionime breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.84B | -95.16M | -4.92% |
| Dec 31, 2024 | 1.93B | 178.18M | 10.15% |
| Dec 31, 2023 | 1.76B | -455.02M | -20.58% |
| Dec 31, 2022 | 2.21B | 360.67M | 19.50% |
| Dec 31, 2021 | 1.85B | 181.34M | 10.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Formosa Optical Technology | 4.46B |
| Vizionfocus | 4.32B |
| St.Shine Optical | 3.63B |
| Pacific Hospital Supply | 2.43B |
| Bioteque | 2.28B |
| Nang Kuang Pharmaceutical | 2.09B |
| ICARES Medicus | 1.31B |
| Crystalvue Medical | 894.60M |